Invention Grant
- Patent Title: Recombinant deamidated gliadin antigen
-
Application No.: US15617979Application Date: 2017-06-08
-
Publication No.: US10921315B2Publication Date: 2021-02-16
- Inventor: Roger Walker , Yabin Lu , Urvee Desai , Daming Shan
- Applicant: Bio-Rad Laboratories, Inc.
- Applicant Address: US CA Hercules
- Assignee: Bio-Rad Laboratories, Inc.
- Current Assignee: Bio-Rad Laboratories, Inc.
- Current Assignee Address: US CA Hercules
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G01N33/531
- IPC: G01N33/531 ; G01N33/564 ; C07K14/415 ; G01N33/68 ; C12N9/10

Abstract:
Methods of diagnosing celiac disease in a subject are provided. In some embodiments, the method comprises contacting a sample of bodily fluid from the subject with an antigen comprising a recombinant or synthetic deamidated gliadin protein, wherein the deamidated gliadin protein comprises a hexamer of peptides each having the sequence of SEQ ID NO:1; and detecting an antibody from the sample that specifically binds to the antigen, thereby diagnosing celiac disease in the subject.
Public/Granted literature
- US20170307633A1 RECOMBINANT DEAMIDATED GLIADIN ANTIGEN Public/Granted day:2017-10-26
Information query
IPC分类: